副腎皮質刺激ホルモン受容体
WordNet
- a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response
PrepTutorEJDIC
- American College Testing / Australian Capital Territory
- =sense organ / 受信装置
- 副腎皮質刺激ホルモン[剤]
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/10/09 16:08:48」(JST)
[Wiki en表示]
Melanocortin 2 receptor (adrenocorticotropic hormone) |
Identifiers |
Symbols |
MC2R ; ACTHR |
External IDs |
OMIM: 607397 MGI: 96928 HomoloGene: 444 IUPHAR: 283 ChEMBL: 1965 GeneCards: MC2R Gene |
Gene ontology |
Molecular function |
• melanocortin receptor activity
• corticotropin receptor activity
• protein binding
|
Cellular component |
• cytoplasm
• plasma membrane
• integral component of plasma membrane
|
Biological process |
• placenta development
• G-protein coupled receptor signaling pathway
• G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
• neuropeptide signaling pathway
• positive regulation of cAMP biosynthetic process
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
Entrez |
4158 |
17200 |
Ensembl |
ENSG00000185231 |
ENSMUSG00000045569 |
UniProt |
Q01718 |
Q64326 |
RefSeq (mRNA) |
NM_000529 |
NM_001271716 |
RefSeq (protein) |
NP_000520 |
NP_001258645 |
Location (UCSC) |
Chr 18:
13.88 – 13.92 Mb |
Chr 18:
68.41 – 68.43 Mb |
PubMed search |
[1] |
[2] |
|
The adrenocorticotropic hormone receptor or ACTH receptor also known as the melanocortin receptor 2 or MC2 receptor is a type of melanocortin receptor (type 2) which is specific for ACTH.[1]
Contents
- 1 Structure
- 2 Tissue and subcellular localization
- 3 Pathology
- 4 See also
- 5 References
- 6 Further reading
- 7 External links
Structure
Both human and bovine ACTH receptors are synthesized as 297 residue long proteins. There is 81% homology between human and bovine sequences.[2] The full length sequence includes seven hydrophobic domains that are predicted as transmembrane segments.[2] In the third intracellular loop of the receptor a protein kinase A and protein kinase c phosphorylation motifs have been detected.[2]
Tissue and subcellular localization
ACTH receptor is found in the zona fasciculata of the human adrenal cortex. Binding of the receptor by ACTH stimulates the production of cortisol. (By contrast, aldosterone production from the zona glomerulosa is stimulated primarily by angiotensin II.)
Protein recognition at the receptor uses energy obtained from the dephosphorylation of ATP to cAMP by adenylate cyclase. ACTH receptors are located on the plasma membrane, and are G protein-coupled receptors.
The ACTH receptor uses cAMP as a secondary messenger.[3][4]
Pathology
Mutations in this receptor cause familial glucocorticoid deficiency type 1, in which patients have high levels of serum ACTH and low levels of cortisol.[5][6]
See also
References
- ^ Beuschlein F, Fassnacht M, Klink A, Allolio B, Reincke M (Mar 2001). "ACTH-receptor expression, regulation and role in adrenocortial tumor formation". European Journal of Endocrinology / European Federation of Endocrine Societies 144 (3): 199–206. doi:10.1530/eje.0.1440199. PMID 11248736.
- ^ a b c Raikhinstein M, Zohar M, Hanukoglu I (Feb 1994). "cDNA cloning and sequence analysis of the bovine adrenocorticotropic hormone (ACTH) receptor". Biochimica Et Biophysica Acta 1220 (3): 329–32. doi:10.1016/0167-4889(94)90157-0. PMID 8305507.
- ^ Hanukoglu I, Feuchtwanger R, Hanukoglu A (Nov 1990). "Mechanism of corticotropin and cAMP induction of mitochondrial cytochrome P450 system enzymes in adrenal cortex cells" (PDF). The Journal of Biological Chemistry 265 (33): 20602–8. PMID 2173715.
- ^ Elias LL, Clark AJ (Oct 2000). "The expression of the ACTH receptor". Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas / Sociedade Brasileira De Biofísica ... [Et Al.] 33 (10): 1245–8. doi:10.1590/S0100-879X2000001000015. PMID 11004726.
- ^ Clark AJ, McLoughlin L, Grossman A (Feb 1993). "Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor". Lancet 341 (8843): 461–2. doi:10.1016/0140-6736(93)90208-X. PMID 8094489.
- ^ Tsigos C, Arai K, Hung W, Chrousos GP (Nov 1993). "Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene". The Journal of Clinical Investigation 92 (5): 2458–61. doi:10.1172/JCI116853. PMC 288430. PMID 8227361.
Further reading
- Cone RD, Mountjoy KG, Robbins LS, Nadeau JH, Johnson KR, Roselli-Rehfuss L, Mortrud MT (May 1993). "Cloning and functional characterization of a family of receptors for the melanotropic peptides". Annals of the New York Academy of Sciences 680: 342–63. doi:10.1111/j.1749-6632.1993.tb19694.x. PMID 8390157.
- Allolio B, Reincke M (1997). "Adrenocorticotropin receptor and adrenal disorders". Hormone Research 47 (4-6): 273–8. doi:10.1159/000185476. PMID 9167964.
- Tatro JB (1997). "Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides". Neuroimmunomodulation 3 (5): 259–84. doi:10.1159/000097281. PMID 9218248.
- Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (Aug 1992). "The cloning of a family of genes that encode the melanocortin receptors". Science 257 (5074): 1248–51. doi:10.1126/science.1325670. PMID 1325670.
- Clark AJ, McLoughlin L, Grossman A (Feb 1993). "Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor". Lancet 341 (8843): 461–2. doi:10.1016/0140-6736(93)90208-X. PMID 8094489.
- Tsigos C, Arai K, Hung W, Chrousos GP (Nov 1993). "Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene". The Journal of Clinical Investigation 92 (5): 2458–61. doi:10.1172/JCI116853. PMC 288430. PMID 8227361.
- Gantz I, Tashiro T, Barcroft C, Konda Y, Shimoto Y, Miwa H, Glover T, Munzert G, Yamada T (Oct 1993). "Localization of the genes encoding the melanocortin-2 (adrenocorticotropic hormone) and melanocortin-3 receptors to chromosomes 18p11.2 and 20q13.2-q13.3 by fluorescence in situ hybridization". Genomics 18 (1): 166–7. doi:10.1006/geno.1993.1448. PMID 8276410.
- Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, Yamada T (Apr 1993). "Molecular cloning of a novel melanocortin receptor". The Journal of Biological Chemistry 268 (11): 8246–50. PMID 8463333.
- Naville D, Barjhoux L, Jaillard C, Faury D, Despert F, Esteva B, Durand P, Saez JM, Begeot M (Apr 1996). "Demonstration by transfection studies that mutations in the adrenocorticotropin receptor gene are one cause of the hereditary syndrome of glucocorticoid deficiency". The Journal of Clinical Endocrinology and Metabolism 81 (4): 1442–8. doi:10.1210/jc.81.4.1442. PMID 8636348.
- Naville D, Jaillard C, Barjhoux L, Durand P, Bégeot M (Jan 1997). "Genomic structure and promoter characterization of the human ACTH receptor gene". Biochemical and Biophysical Research Communications 230 (1): 7–12. doi:10.1006/bbrc.1996.5911. PMID 9020063.
- Yang YK, Ollmann MM, Wilson BD, Dickinson C, Yamada T, Barsh GS, Gantz I (Mar 1997). "Effects of recombinant agouti-signaling protein on melanocortin action". Molecular Endocrinology 11 (3): 274–80. doi:10.1210/me.11.3.274. PMID 9058374.
- Naville D, Barjhoux L, Jaillard C, Saez JM, Durand P, Bégeot M (Apr 1997). "Stable expression of normal and mutant human ACTH receptor: study of ACTH binding and coupling to adenylate cyclase". Molecular and Cellular Endocrinology 129 (1): 83–90. doi:10.1016/S0303-7207(97)04043-4. PMID 9175632.
- Penhoat A, Naville D, Jaillard C, Durand P, Bégeot M (May 1997). "Presence of multiple functional polyadenylation signals in the 3'-untranslated region of human corticotropin receptor cDNA". Biochimica Et Biophysica Acta 1356 (3): 249–52. doi:10.1016/S0167-4889(97)00031-1. PMID 9194567.
- Ishii T, Ogata T, Sasaki G, Sato S, Kinoshita EI, Matsuo N (Sep 2000). "Novel mutations of the ACTH receptor gene in a female adult patient with adrenal unresponsiveness to ACTH". Clinical Endocrinology 53 (3): 389–92. doi:10.1046/j.1365-2265.2000.01040.x. PMID 10971458.
- Flück CE, Martens JW, Conte FA, Miller WL (Sep 2002). "Clinical, genetic, and functional characterization of adrenocorticotropin receptor mutations using a novel receptor assay". The Journal of Clinical Endocrinology and Metabolism 87 (9): 4318–23. doi:10.1210/jc.2002-020501. PMID 12213892.
- Swords FM, Baig A, Malchoff DM, Malchoff CD, Thorner MO, King PJ, Hunyady L, Clark AJ (Dec 2002). "Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity". Molecular Endocrinology 16 (12): 2746–53. doi:10.1210/me.2002-0099. PMID 12456795.
- Roy S, Rached M, Gallo-Payet N (Jul 2007). "Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells". Molecular Endocrinology 21 (7): 1656–69. doi:10.1210/me.2007-0041. PMID 17456795.
External links
- "Melanocortin Receptors: MC2". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.
- MC2 Receptor at the US National Library of Medicine Medical Subject Headings (MeSH)
Neuropeptidergics
|
|
CGRP |
- Agonists: Amylin
- CGRP
- Pramlintide
- Antagonists: BI 44370 TA
- BMS-927711
- CGRP (8-37)
- MK-3207
- Olcegepant
- Rimegepant
- SB-268262
- Telcagepant
- Ubrogepant
|
|
Cholecystokinin |
CCKA
|
- Agonists: Cholecystokinin
- CCK-4
- Antagonists: Amiglumide
- Asperlicin
- Devazepide
- Dexloxiglumide
- Lintitript
- Lorglumide
- Loxiglumide
- Pranazepide
- Proglumide
- Tarazepide
- Tomoglumide
|
|
CCKB
|
- Agonists: Cholecystokinin
- CCK-4
- Gastrin
- Antagonists: CI-988 (PD-134,308)
- Itriglumide
- L-365,360
- Netazepide
- Proglumide
- Spiroglumide
|
|
|
CRH |
CRF1
|
- Agonists: Cortagine
- Corticorelin
- Corticotropin releasing hormone
- Sauvagine
- Stressin I
- Urocortin
- Antagonists: Antalarmin
- Astressin-B
- CP-154,526
- Emicerfont
- Hypericin
- LWH-234
- NBI-27914
- Pexacerfont
- R-121,919
- TS-041
- Verucerfont
|
|
CRF2
|
- Agonists: Corticorelin
- Corticotropin releasing hormone
- Sauvagine
- Urocortin
|
|
|
Galanin |
GAL1
|
- Agonists: Galanin
- Galanin (1-15)
- Galanin-like peptide
- Galmic
- Galnon
- Antagonists: C7
- Dithiepine-1,1,4,4-tetroxide
- Galantide (M15)
- M32
- M35
- M40
- SCH-202596
|
|
GAL2
|
- Agonists: Galanin
- Galanin (1-15)
- Galanin (2-11)
- Galanin-like peptide
- Galmic
- Galnon
- J18
- Antagonists: C7
- Galantide (M15)
- M32
- M35
- M40
- M871
|
|
GAL3
|
- Agonists: Galanin
- Galanin (1-15)
- Galmic
- Galnon
- Antagonists: C7
- Galantide (M15)
- GalR3ant
- HT-2157
- M32
- M35
- M40
- SNAP-37889
- SNAP-398299
|
|
|
Ghrelin/GHS |
- Agonists: Adenosine
- Alexamorelin
- Anamorelin
- Capromorelin
- CP-464709
- Cortistatin-14
- Examorelin (hexarelin)
- Ghrelin (lenomorelin)
- GHRP-1
- GHRP-3
- GHRP-4
- GHRP-5
- GHRP-6
- Ibutamoren (MK-677)
- Ipamorelin
- L-692,585
- LY-426410
- LY-444711
- Macimorelin
- Pralmorelin (GHRP-2)
- Relamorelin
- SM-130,686
- Tabimorelin
- Ulimorelin
- Antagonists: A-778,193
- Cortistatin-8
- (D-Lys3)-GHRP-6
- YIL-781
|
|
MCH |
MCH1
|
- Agonists: Melanin concentrating hormone
- Antagonists: ATC-0065
- ATC-0175
- GW-803,430
- NGD-4715
- SNAP-7941
- SNAP-94847
|
|
MCH2
|
- Agonists: Melanin concentrating hormone
|
|
|
Melanocortin |
MC1
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- BMS-470,539
- Bremelanotide
- HS-014
- HS-024
- Melanotan II
- Modimelanotide
- PL-8177
- SHU-8914
- SHU-9005
- SHU-9119
- SNAP-7941
|
|
MC2
|
- Agonists: ACTH (corticotropin)
- Alsactide
- Codactide
- Giractide
- Norleusactide (pentacosactride)
- Seractide
- Tetracosactide (tetracosactrin, cosyntropin)
- Tosactide (octacosactrin)
- Tricosactide
- Tridecactide
|
|
MC3
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- Bremelanotide
- Melanotan II
- Modimelanotide
- PG-931
- Antagonists: AGRP
- ASIP
- HS-014
- ML-00253764
- PG-106
- SHU-8914
- SHU-9005
- SHU-9119
|
|
MC4
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- AZD2820
- BIM-22493
- Bremelanotide
- LY-2112688
- Melanotan II
- MK-0493
- Modimelanotide
- PF-00446687
- PG-931
- PL-6983
- Ro 27-3225
- Setmelanotide
- THIQ
- Antagonists: AGRP
- ASIP
- HS-014
- HS-024
- HS-131
- JKC-363
- MCL-0020
- MCL-0042
- MCL-0129
- ML-00253764
- MPB-10
- SHU-8914
- SHU-9005
- SHU-9119
|
|
MC5
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- Bremelanotide
- HS-014
- HS-024
- Melanotan II
- Modimelanotide
- SHU-8914
- SHU-9005
- SHU-9119
- Antagonists: ASIP
- ML-00253764
|
|
Unsorted
|
- Agonists: Alsactide
- Codactide
- Giractide
- Norleusactide (pentacosactride)
- Seractide
- Tetracosactide (tetracosactrin, cosyntropin)
- Tosactide (octacosactrin)
- Tricosactide
- Tridecactide
|
|
|
Neuropeptide S |
|
|
Neuropeptide Y |
Y1
|
- Agonists: Neuropeptide Y
- Peptide YY
- Antagonists: BIBO-3304
- BIBP-3226
- BVD-10
- GR-231,118
- PD-160,170
|
|
Y2
|
- Agonists: 2-Thiouridine 5'-triphosphate
- Neuropeptide Y
- Neuropeptide Y (13-36)
- Peptide YY
- Peptide YY (3-36)
- Antagonists: BIIE-0246
- JNJ-5207787
- SF-11
|
|
Y4
|
- Agonists: GR-231,118
- Neuropeptide Y
- Pancreatic polypeptide
- Peptide YY
|
|
Y5
|
- Agonists: BWX-46
- Neuropeptide Y
- Peptide YY
- Antagonists: CGP-71683
- FMS-586
- L-152,804
- Lu AA-33810
- MK-0557
- NTNCB
- Velneperit (S-2367)
|
|
|
Neurotensin |
NTS1
|
- Agonists: Neurotensin
- Neuromedin N
- Antagonists: Meclinertant
- SR-142,948
|
|
NTS2
|
- Antagonists: Levocabastine
- SR-142,948
|
|
|
Opioid |
See here instead.
|
|
Orexin |
OX1
|
- Agonists: Orexin-A
- Orexin-B
- Antagonists: ACT-335827
- ACT-462206
- Almorexant
- Filorexant
- Lemborexant
- SB-334,867
- SB-408,124
- SB-649,868
- Suvorexant
- TCS-1102
|
|
OX2
|
- Agonists: Orexin-A
- Orexin-B
- SB-668,875
- Antagonists: ACT-335827
- ACT-462206
- Almorexant
- EMPA
- Filorexant
- JNJ-10397049
- JNJ-42847922
- Lemborexant
- MK-1064
- SB-649,868
- Suvorexant
- TCS-1102
- TCS-OX2-29
|
|
|
Oxytocin |
- Agonists: Aspartocin
- Carbetocin
- Cargutocin
- Demoxytocin
- Merotocin
- Nacartocin
- Oxytocin
- TC OT 39
- TGOT
- Vasotocin (argiprestocin)
- WAY-267,464
- Antagonists: Atosiban
- Barusiban
- Epelsiban
- Erlosiban
- L-368,899
- L-371,257
- L-372,662
- OBE001
- Retosiban
- SSR-126,768
- Tocinoic acid
- WAY-162,720
- Metabolism inhibitors: Amastatin
- Bestatin (ubenimex)
- EDTA
- L-Methionine
- Leupeptin
- o-Phenanthroline
- Phosphoramidon
- Puromycin
|
|
Tachykinin |
NK1
|
- Antagonists: Aprepitant
- Befetupitant
- Burapitant
- Casopitant
- CI-1021
- CP-96,345
- CP-99,994
- CP-122,721
- Dapitant
- Ezlopitant
- Figopitant
- FK-888
- Fosaprepitant
- GR-203,040
- GW-597,599
- HSP-117
- L-733,060
- L-741,671
- L-743,310
- L-758,298
- Lanepitant
- LY-306,740
- Maropitant
- Netupitant
- NKP-608
- Nolpitantium besilate
- Orvepitant
- Rolapitant
- RP-67,580
- SDZ NKT 343
- Serlopitant
- Telmapitant
- Tradipitant
- Vestipitant
- Vofopitant
|
|
NK2
|
- Antagonists: GR-159,897
- Ibodutant
- Nepadutant
- Saredutant
|
|
NK3
|
- Antagonists: Osanetant
- Talnetant
|
|
|
Vasopressin |
V1A
|
- Agonists: Felypressin
- Lypressin
- Ornipressin
- Selepressin
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: Atosiban
- Conivaptan
- FR-218944
- JNJ-17079166
- JNJ-17308616
- LY-307174
- PF-184563
- Relcovaptan
- RG7314
- SRX246
- SRX251
- TC OT 39
- WAY-267,464
- YM-218
- YM-471
- YM-35471
|
|
V1B
|
- Agonists: Desmopressin
- Felypressin
- Lypressin
- Ornipressin
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: ABT-436
- Nelivaptan
- ORG-52186
|
|
V2
|
- Agonists: Desmopressin
- Felypressin
- Lypressin
- Ornipressin
- TC OT 39
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: Conivaptan
- JNJ-17079166
- Lixivaptan
- Mozavaptan
- RWJ-351647
- Satavaptan
- Tolvaptan
- YM-471
- YM-35471
|
|
Unsorted
|
- Antagonists: Ribuvaptan
- RWJ-339489
- VMAX-367
- VMAX-372
- VMAX-382
- YM-222546
|
|
|
See also: Peptidergics
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Tipepidine, a non-narcotic antitussive, exerts an antidepressant-like effect in the forced swimming test in adrenocorticotropic hormone-treated rats.
- Kawaura K1, Ogata Y1, Honda S1, Soeda F1, Shirasaki T1, Takahama K2.
- Behavioural brain research.Behav Brain Res.2016 Apr 1;302:269-78. doi: 10.1016/j.bbr.2015.12.008. Epub 2015 Dec 29.
- We investigated whether tipepidine exerts an antidepressant-like effect in the forced swimming test in adrenocorticotropic hormone (ACTH)-treated rats, which is known as a treatment-resistant depression model, and we studied the pharmacological mechanisms of the effects of tipepidine. Male Wistar ra
- PMID 26738969
- The melanocortin ACTH 1-39 promotes protection of oligodendrocytes by astroglia.
- Lisak RP1, Nedelkoska L1, Benjamins JA2.
- Journal of the neurological sciences.J Neurol Sci.2016 Mar 15;362:21-6. doi: 10.1016/j.jns.2016.01.009. Epub 2016 Jan 7.
- Damage to myelin and oligodendroglia (OL) in multiple sclerosis (MS) results from a wide array of mechanisms including excitotoxicity, neuroinflammation and oxidative stress. We previously showed that ACTH 1-39, a melanocortin, protects OL in mixed glial cultures and enriched OL cultures, inhibiting
- PMID 26944112
- Hsa-miR-34a mediated repression of corticotrophin releasing hormone receptor 1 regulates pro-opiomelanocortin expression in patients with complex regional pain syndrome.
- Shenoda BB1, Alexander GM2, Ajit SK3.
- Journal of translational medicine.J Transl Med.2016 Mar 3;14(1):64. doi: 10.1186/s12967-016-0820-1.
- BACKGROUND: Ketamine provides relief for a subset of patients with complex regional pain syndrome (CRPS). The poor responders had a lower body mass index (BMI) relative to responders. Regulation of proopiomelanocortin (POMC) expression is crucial in normal body weight homeostasis. The main objective
- PMID 26940669
Japanese Journal
- Medical Management of Functioning Pituitary Adenoma: An Update
- OKI Yutaka
- Neurologia medico-chirurgica, 2014
- … In patients with acromegaly, dopamine agonists, somatostatin analogues, and growth hormone receptor antagonist have been used as a monotherapy or the combination, and the high remission rate can be achieved. … Pasireotide having high affinity to type 5 somatostatin receptors will be available for the patients presenting resistance against type 2 receptor agonists, such as octreotide and lanreotide. …
- NAID 130004704540
- Retinoic acid receptor-α up-regulates proopiomelanocortin gene expression in AtT20 corticotroph cells
- Uruno Akira,Saito-Hakoda Akiko,Yokoyama Atsushi,Kogure Naotaka,Matsuda Ken,Parvin Rehana,Shimizu Kyoko,Sato Ikuko,Kudo Masataka,Yoshikawa Takeo,Kagechika Hiroyuki,Iwasaki Yasumasa,Ito Sadayoshi,Sugawara Akira
- Endocrine Journal 61(11), 1105-1114, 2014
- … Cushing's disease is a disorder caused by excessive ACTH secretion from a corticotroph tumor of the pituitary gland. … Retinoic acid (RA) has been reported to suppress adrenocorticotropic hormone (ACTH) secretion in Cushing's disease. … However, the role of RA receptor (RAR) in proopiomelanocortin (Pomc) gene expression remains uncertain. … Surprisingly, a synthetic RARα agonist Am80 increased Pomc mRNA expression, CRH-induced ACTH secretion, and Pomc promoter activity. …
- NAID 130004677954
- Effects of Bupropion and Pramipexole on Cell Proliferation in the Hippocampus of Adrenocorticotropic Hormone-Treated Rats
- Onoue Yuka,Kuwatsuka Keiko,Miyazaki Ikuko,Asanuma Masato,Kitamura Yoshihisa,Sendo Toshiaki
- Biological and Pharmaceutical Bulletin 37(2), 327-330, 2014
- … The dopamine reuptake inhibitor bupropion and dopamine D2/3 receptor agonist pramipexole have been clinically proven to improve both depression and treatment-resistant depression. … We examined its influence on the duration of immobility during the forced swim test in adrenocorticotropic hormone (ACTH)-treated rats and further analyzed the possible role of the dopamine nerve system in this effect. …
- NAID 130003390932
Related Links
- The adrenocorticotropic hormone receptor or ACTH receptor also known as the melanocortin receptor 2 or MC2 receptor is a type of melanocortin receptor (type 2) which is specific for ACTH.
- G protein-coupled receptors (GPCRs) constitute a vast protein family that encompasses a wide range of functions, including various autocrine, paracrine and endocrine processes. They show considerable diversity at the sequence level, ...
★リンクテーブル★
[★]
- 英
- adrenocorticotropic hormone receptor, ACTH receptor
[★]
[★]
[★]
副腎皮質刺激ホルモン adrenocorticotropic hormone